Should phenotype of previous preterm birth influence management of women with short cervix in subsequent pregnancy? Comparison of vaginal progesterone and Arabin pessary.
Administration, Intravaginal
Adult
Cervical Length Measurement
Cervix Uteri
/ diagnostic imaging
Female
Fetal Membranes, Premature Rupture
/ prevention & control
Gestational Age
Humans
Pessaries
Pregnancy
Premature Birth
/ prevention & control
Progesterone
/ administration & dosage
Progestins
/ administration & dosage
Retrospective Studies
Treatment Outcome
Arabin pessary
PPROM
preterm birth
short cervix
vaginal progesterone
Journal
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
07
02
2018
revised:
01
06
2018
accepted:
05
06
2018
pubmed:
20
6
2018
medline:
2
5
2019
entrez:
20
6
2018
Statut:
ppublish
Résumé
To investigate whether the classification of a previous spontaneous preterm birth (sPTB) as preterm labor (PTL) with intact membranes (IM) or as preterm prelabor rupture of membranes (PPROM) impacts the efficacy of cervical pessary or vaginal progesterone for prevention of sPTB in pregnant women with short cervix on transvaginal ultrasound. This was a retrospective cohort study of asymptomatic high-risk singleton pregnancies with a short cervix and history of sPTB, treated using Arabin pessary or vaginal progesterone for primary PTB prevention, conducted at four European hospitals. A log-rank test on Kaplan-Meier curves was used to assess the difference in performance of pessary and progesterone, according to history of PTL-IM or PPROM. Linear regression analysis was used to evaluate significant predictors of gestational age at delivery. Between 2008 and 2015, 170 women were treated with a pessary and 88 with vaginal progesterone. In women treated with a pessary, rate of sPTB < 34 weeks was 16% in those with a history of PTL-IM and 55% in those with a history of PPROM. In women treated with progesterone, rate of sPTB < 34 weeks was 13% in those with a history of PTL-IM and 21% in those with a history of PPROM. Treatment with a pessary resulted in earlier delivery in women with previous PPROM than in any other subgroup (P < 0.0001). Linear regression analysis showed a clear effect of PPROM history (P < 0.0001), combination of PPROM history and treatment (P = 0.0003) and cervical length (P = 0.0004) on gestational age at birth. Cervical pessary may be a less efficacious treatment option for women with previous PPROM; however, these results require prospective validation before change in practice is recommended. Phenotype of previous preterm birth may be an important risk predictor and treatment effect modifier; this information should be reported in future clinical trials. © 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
Identifiants
pubmed: 29920812
doi: 10.1002/uog.19118
pmc: PMC6593812
doi:
Substances chimiques
Progestins
0
Progesterone
4G7DS2Q64Y
Types de publication
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
529-534Informations de copyright
© 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
Références
J Matern Fetal Neonatal Med. 2006 Dec;19(12):763-72
pubmed: 17190686
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
Ultrasound Obstet Gynecol. 2009 Apr;33(4):459-64
pubmed: 19277949
Am J Obstet Gynecol. 2012 Feb;206(2):119-23
pubmed: 22177191
Lancet. 2012 May 12;379(9828):1800-6
pubmed: 22475493
Am J Perinatol. 2013 Apr;30(4):283-8
pubmed: 22875662
Am J Obstet Gynecol. 2013 Jan;208(1):42.e1-42.e18
pubmed: 23157855
Obstet Gynecol Int. 2013;2013:576723
pubmed: 23606848
Ultrasound Obstet Gynecol. 2013 Oct;42(4):426-33
pubmed: 23671013
BJOG. 2014 Mar;121(4):417-21
pubmed: 24314110
PLoS One. 2014 Sep 29;9(9):e108578
pubmed: 25264875
Int Urogynecol J. 2016 Feb;27(2):219-27
pubmed: 26377332
J Matern Fetal Neonatal Med. 2016 Oct;29(19):3153-61
pubmed: 26701680
N Engl J Med. 2016 Mar 17;374(11):1044-52
pubmed: 26981934
Sci Transl Med. 2016 Aug 3;8(350):350ra102
pubmed: 27488896
Microbiome. 2017 Jan 19;5(1):6
pubmed: 28103952
JAMA. 2017 Dec 19;318(23):2317-2324
pubmed: 29260226